• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

心力衰竭患者水肿的病因和治疗。

Causes and treatment of oedema in patients with heart failure.

机构信息

Department of Cardiology, Hull York Medical School, University of Hull, Castle Hill Hospital, Cottingham HU16 5JQ, UK.

出版信息

Nat Rev Cardiol. 2013 Mar;10(3):156-70. doi: 10.1038/nrcardio.2012.191. Epub 2013 Jan 15.

DOI:10.1038/nrcardio.2012.191
PMID:23319101
Abstract

Oedema is one of the fundamental features of heart failure, but the pathophysiology of oedema varies. Patients present along a spectrum ranging from acute pulmonary oedema to gross fluid retention and peripheral oedema (anasarca). In patients with pure pulmonary oedema, the problem is one of acute haemodynamic derangement; the patient does not have excess fluid, but pulmonary venous pressure rises such that the rate of fluid transudation into the interstitium of the lung exceeds the capacity of the pulmonary lymphatics to drain away the fluid. Conversely, in patients with peripheral oedema, the problem is one of fluid retention. Understanding the causes of oedema will enable straightforward, correct management of the condition. For patients with acute pulmonary oedema, vasodilatation is important to reduce cardiac filling pressures. For patients with fluid retention, removing the fluid, using either diuretics or mechanical means, is the most important consideration.

摘要

水肿是心力衰竭的基本特征之一,但水肿的病理生理学机制有所不同。患者表现为从急性肺水肿到大量液体潴留和外周水肿(全身性水肿)的连续谱。在单纯性肺水肿患者中,问题是急性血流动力学紊乱;患者没有多余的液体,但肺静脉压升高,导致液体渗出到肺间质的速度超过肺淋巴管排出液体的能力。相反,在外周水肿患者中,问题是液体潴留。了解水肿的原因将有助于对该病症进行简单、正确的管理。对于急性肺水肿患者,血管舒张对于降低心脏充盈压很重要。对于液体潴留患者,最重要的考虑因素是去除液体,无论是使用利尿剂还是机械手段。

相似文献

1
Causes and treatment of oedema in patients with heart failure.心力衰竭患者水肿的病因和治疗。
Nat Rev Cardiol. 2013 Mar;10(3):156-70. doi: 10.1038/nrcardio.2012.191. Epub 2013 Jan 15.
2
[Non-cardiac pulmonary edema: an enigma today].[非心源性肺水肿:当今的一个谜团]
Minerva Med. 1985 Oct 13;76(39):1819-22.
3
Pulmonary edema.肺水肿
Hosp Pract (Off Ed). 1986 May 15;21(5):87-91, 94-8, 101.
4
Oedema: causes, physiology and nursing management.
Nurs Stand. 2004;18(51):45-51; quiz 52. doi: 10.7748/ns.18.51.45.s54.
5
[Low-capillary-pressure pulmonary edema occurring in the acute phase of myocardial infarction].[心肌梗死急性期发生的低毛细血管压性肺水肿]
Ann Fr Anesth Reanim. 1984;3(1):41-3. doi: 10.1016/s0750-7658(84)80096-9.
6
Revascularization of atherosclerotic renal artery stenosis for chronic heart failure versus acute pulmonary oedema.针对慢性心力衰竭与急性肺水肿的动脉粥样硬化性肾动脉狭窄血管重建术
Nephrology (Carlton). 2018 May;23(5):411-417. doi: 10.1111/nep.13038.
7
[Intra- and extravascular volumes in congestive heart failure and their redistribution following extracorporeal ultrafiltration].[充血性心力衰竭时的血管内和血管外容量及其在体外超滤后的再分布]
Cardiologia. 1998 Nov;43(11):1193-200.
8
Interstitial colloid osmotic and hydrostatic pressures in human subcutaneous tissue during early stages of heart failure.
Clin Physiol. 1984 Aug;4(4):283-97. doi: 10.1111/j.1475-097x.1984.tb00804.x.
9
Acute cardiogenic pulmonary oedema: reflecting on the management of an intensive care unit patient.急性心源性肺水肿:反思一位 ICU 患者的治疗。
Nurs Crit Care. 2011 Jul-Aug;16(4):193-200. doi: 10.1111/j.1478-5153.2011.00410.x.
10
Pathogenesis of oedema in chronic severe anaemia: studies of body water and sodium, renal function, haemodynamic variables, and plasma hormones.慢性重度贫血中水肿的发病机制:对机体水和钠、肾功能、血流动力学变量及血浆激素的研究
Br Heart J. 1993 Oct;70(4):357-62. doi: 10.1136/hrt.70.4.357.

引用本文的文献

1
Methylations in dilated cardiomyopathy and heart failure.扩张型心肌病与心力衰竭中的甲基化
Front Cardiovasc Med. 2025 Apr 11;12:1559550. doi: 10.3389/fcvm.2025.1559550. eCollection 2025.
2
Molecular Mechanisms Underlying Heart Failure and Their Therapeutic Potential.心力衰竭的分子机制及其治疗潜力。
Cells. 2025 Feb 20;14(5):324. doi: 10.3390/cells14050324.
3
Imaging of Congestion in Cardio-renal Syndrome.心肾综合征中充血的影像学检查

本文引用的文献

1
Serelaxin, recombinant human relaxin-2, for treatment of acute heart failure (RELAX-AHF): a randomised, placebo-controlled trial.重组人松弛素-2 治疗急性心力衰竭(RELAX-AHF)的随机、安慰剂对照试验。
Lancet. 2013 Jan 5;381(9860):29-39. doi: 10.1016/S0140-6736(12)61855-8. Epub 2012 Nov 7.
2
An orally active TRPV4 channel blocker prevents and resolves pulmonary edema induced by heart failure.一种口服有效的 TRPV4 通道阻滞剂可预防和治疗心力衰竭引起的肺水肿。
Sci Transl Med. 2012 Nov 7;4(159):159ra148. doi: 10.1126/scitranslmed.3004276.
3
Ultrafiltration in decompensated heart failure with cardiorenal syndrome.
Curr Heart Fail Rep. 2025 Feb 25;22(1):10. doi: 10.1007/s11897-025-00695-z.
4
Realizing real-time optical molecular imaging in peripheral nerve tissue via Rhodamine B.通过罗丹明B实现外周神经组织的实时光学分子成像。
Front Med (Lausanne). 2024 Nov 26;11:1461520. doi: 10.3389/fmed.2024.1461520. eCollection 2024.
5
Pathophysiology of Congestion in Heart Failure: A Contemporary Review.心力衰竭中充血的病理生理学:当代综述
Card Fail Rev. 2024 Sep 25;10:e13. doi: 10.15420/cfr.2024.07. eCollection 2024.
6
Kidney protection strategy lowers the risk of contrast-associated acute kidney injury.肾脏保护策略降低了造影剂相关急性肾损伤的风险。
PLoS One. 2024 Oct 24;19(10):e0312618. doi: 10.1371/journal.pone.0312618. eCollection 2024.
7
High-dimensional Iterative Causal Forest (hdiCF) for Subgroup Identification Using Health Care Claims Data.使用医疗保健理赔数据进行亚组识别的高维迭代因果森林(hdiCF)
Am J Epidemiol. 2024 Sep 5. doi: 10.1093/aje/kwae322.
8
Chronic Edema Management of the Lower Extremities.下肢慢性水肿的管理
Cureus. 2024 Jul 4;16(7):e63840. doi: 10.7759/cureus.63840. eCollection 2024 Jul.
9
Association of COPD with adverse outcomes in heart failure patients with preserved ejection fraction.射血分数保留的心力衰竭患者中慢性阻塞性肺疾病与不良结局的关联
ESC Heart Fail. 2025 Apr;12(2):799-808. doi: 10.1002/ehf2.14958. Epub 2024 Jul 12.
10
The Congestion "Pandemic" in Acute Heart Failure Patients.急性心力衰竭患者的充血“大流行”
Biomedicines. 2024 Apr 24;12(5):951. doi: 10.3390/biomedicines12050951.
心力衰竭合并心肾综合征失代偿期的超滤治疗。
N Engl J Med. 2012 Dec 13;367(24):2296-304. doi: 10.1056/NEJMoa1210357. Epub 2012 Nov 6.
4
Cardiorenal outcomes after slow continuous ultrafiltration therapy in refractory patients with advanced decompensated heart failure.难治性晚期失代偿性心力衰竭患者缓慢持续超滤治疗后的心肾结局。
J Am Coll Cardiol. 2012 Nov 6;60(19):1906-12. doi: 10.1016/j.jacc.2012.08.957. Epub 2012 Oct 10.
5
Clinical trials with endothelin receptor antagonists: what went wrong and where can we improve?内皮素受体拮抗剂的临床试验:哪里出了问题,我们可以如何改进?
Life Sci. 2012 Oct 15;91(13-14):528-39. doi: 10.1016/j.lfs.2012.07.034. Epub 2012 Aug 6.
6
Low sodium versus normal sodium diets in systolic heart failure: systematic review and meta-analysis.收缩性心力衰竭中低钠饮食与正常钠饮食的比较:系统评价与荟萃分析
Heart. 2013 Mar 12. doi: 10.1136/heartjnl-2012-302337.
7
Cinaciguat, a soluble guanylate cyclase activator: results from the randomized, controlled, phase IIb COMPOSE programme in acute heart failure syndromes.西那卡塞,一种可溶性鸟苷酸环化酶激活剂:来自急性心力衰竭综合征的随机、对照、IIb 期 COMPOSE 研究的结果。
Eur J Heart Fail. 2012 Sep;14(9):1056-66. doi: 10.1093/eurjhf/hfs093. Epub 2012 Jun 19.
8
Intraaortic balloon counterpulsation in acute myocardial infarction complicated by cardiogenic shock: design and rationale of the Intraaortic Balloon Pump in Cardiogenic Shock II (IABP-SHOCK II) trial.主动脉内球囊反搏在急性心肌梗死合并心源性休克中的应用:主动脉内球囊泵在心源性休克 II 期试验(IABP-SHOCK II)的设计和原理。
Am Heart J. 2012 Jun;163(6):938-45. doi: 10.1016/j.ahj.2012.03.012.
9
ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC.《2012年欧洲心脏病学会急性和慢性心力衰竭诊断与治疗指南》:欧洲心脏病学会2012年急性和慢性心力衰竭诊断与治疗特别工作组编著。与欧洲心脏病学会心力衰竭协会(HFA)合作制定。
Eur Heart J. 2012 Jul;33(14):1787-847. doi: 10.1093/eurheartj/ehs104. Epub 2012 May 19.
10
The acute haemodynamic effect of nebulised frusemide in stable, advanced heart failure.雾化呋塞米对稳定期、晚期心力衰竭患者急性血液动力学的影响。
Heart Lung Circ. 2012 May;21(5):260-6. doi: 10.1016/j.hlc.2012.03.002. Epub 2012 Apr 13.